Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Neuroscience Antibody and Assay Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


The future of the neuroscience antibody and assay market looks promising with opportunities in the pharmaceutical and biotechnology companies, academic & research institutes, and hospitals & diagnostic centers. The global neuroscience antibody and assay market is expected to grow with a CAGR of 9%-11% from 2020 to 2025. The major drivers for this market are increasing neurological diseases and rising investments in neuroscience research.

A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global neuroscience antibody and assay market report, please download the report brochure.
 

 
Neuroscience Antibody and Assay Market by Product, Technology, Application and End User
 
In this market, consumables and reagents is the largest product type of neuroscience antibody and assay, whereas pharmaceutical and biotechnology companies is the largest end user. Growth in various segments of the neuroscience antibody and assay market are given below:
 
 
Neuroscience Antibody and Assay Market by Segments


 
The study includes trends and forecast for the global neuroscience antibody and assay market by product, technology, application, end user, and region as follows:

By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Consumables and Reagents
  • Instruments 

By Technology [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Immunochemistry/Immunoassays 
  • Molecular Diagnostics 
  • Clinical Chemistry 
  • Other Technologies 

By Application [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Research 
  • In Vitro Diagnostics 
  • Drug Discovery and Development 

By End User [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Pharmaceutical & Biotechnology Companies 
  • Academic & Research Institutes 
  • Hospitals & Diagnostic Centers 

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
  • North America
    • United States
    • Canada 
    • Mexico
  • Europe
    • United Kingdom
    • Spain
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • The Rest of the World
    • Brazil

Some of the neuroscience antibody and assay model companies profiled in this report include Thermo Fisher Scientific, Abcam, Merck, Siemens, Cell Signaling Technology, F. Hoffmann-La Roche, GenScript, and BioLegend.

Lucintel forecasts that consumables and reagents segment will remain the largest product segment over the forecast period due to consistent usage of consumables and their frequent demand, and rising government initiatives in the Genomics and Proteomics research sector.

Within this market, pharmaceutical and biotechnology companies will remain the largest segment by end user over the forecast period due to the high uptake of neuroscience antibodies in the drug discovery and development process.

North America will remain the largest region over the forecast period due to increasing investments for the development of structure-based drug designs, growing research in the field of genomics and proteomics, rising demand for high-quality research tools for data reproducibility, and the focus of stakeholders on research projects involving proteins, associated biomolecules, and genes. 




 
Features of the Global Neuroscience Antibody and Assay Market
 
  • Market Size Estimates: Global neuroscience antibody and assay market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
  • Segmentation Analysis: Global neuroscience antibody and assay market size by various segments, such as product, technology, application, and end user in terms of value.
  • Regional Analysis: Global neuroscience antibody and assay market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different product, technology, application, end user, and region for the global neuroscience antibody and assay market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global neuroscience antibody and assay market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.




 
This report answers following key questions
 
Q.1 What are some of the most promising potential, high-growth opportunities for the global neuroscience antibody and assay market by product (consumables and reagents and instruments), technology (immunochemistry/immunoassays, molecular diagnostics, clinical chemistry, and other technologies), application (research, in vitro diagnostics, drug discovery and development), end user (pharmaceutical & biotechnology companies, academic & research institutes and hospitals & diagnostic centers), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global neuroscience antibody and assay market?
Q.5 What are the business risks and threats to the global neuroscience antibody and assay market?
Q.6 What are the emerging trends in this neuroscience antibody and assay market and the reasons behind them?
Q.7 What are some changing demands of customers in this neuroscience antibody and assay market?
Q.8 What are the new developments in this neuroscience antibody and assay market? Which companies are leading these developments?
Q.9 Who are the major players in this neuroscience antibody and assay market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this neuroscience antibody and assay market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global neuroscience antibody and assay market?

 


Report Scope



Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates)		 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Consumables and Reagents and Instruments), Technology (Immunochemistry/Immunoassays, Molecular Diagnostics, Clinical Chemistry, and Other Technologies), Application (Research, In Vitro Diagnostics, Drug Discovery and Development), End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Hospitals & Diagnostic Centers)

Regional Scope

North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost

Table of Contents


1. Executive Summary

2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Neuroscience Antibody and Assay Market Trends and Forecast
3.3: Global Neuroscience Antibody and Assay Market by Product
3.3.1: Consumables and Reagents
3.3.2: Instruments
3.4: Global Neuroscience Antibody and Assay Market by Technology
3.4.1: Immunochemistry/Immunoassays 
3.4.2: Molecular Diagnostics 
3.4.3: Clinical Chemisry 
3.4.4: Other Technologies 
3.5: Global Neuroscience Antibody and Assay Market by Application
3.5.1: Research 
3.5.2: In Vitro Diagnostics 
3.5.3: Drug Discovery and Development 
3.6: Global Neuroscience Antibody and Assay Market by End User
3.6.1: Pharmaceutical & Biotechnology Companies 
3.6.2: Academic & Research Institutes 
3.6.3: Hospitals & Diagnostic Centers 

4. Market Trends and Forecast Analysis by Region
4.1: Global Neuroscience Antibody and Assay Market by Region
4.2: North American Neuroscience Antibody and Assay Market
4.2.1: Market by Product: Consumables and Reagents and Instruments
4.2.2: Market by Technology: Immunochemistry/Immunoassays, Molecular Diagnostics, Clinical Chemistry, and Other Technologies
4.2.3: Market by Application: Research, In Vitro Diagnostics, Drug Discovery and Development
4.2.4: Market by End User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers 
4.2.5: The United States Neuroscience Antibody and Assay Market
4.2.6: The Canadian Neuroscience Antibody and Assay Market
4.2.7: The Mexican Neuroscience Antibody and Assay Market
4.3: European Neuroscience Antibody and Assay Market
4.3.1: Market by Product: Consumables and Reagents and Instruments
4.3.2: Market by Technology: Immunochemistry/Immunoassays, Molecular Diagnostics, Clinical Chemistry, and Other Technologies
4.3.3: Market by Application: Research, In Vitro Diagnostics, Drug Discovery and Development
4.3.4: Market by End User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers 
4.3.5: The United Kingdom Neuroscience Antibody and Assay Market
4.3.6: The Spanish Neuroscience Antibody and Assay Market
4.3.7: The German Neuroscience Antibody and Assay Market
4.3.8: The French Neuroscience Antibody and Assay Market
4.4: APAC Neuroscience Antibody and Assay Market
4.4.1: Market by Product: Consumables and Reagents and Instruments
4.4.2: Market by Technology: Immunochemistry/Immunoassays, Molecular Diagnostics, Clinical Chemistry, and Other Technologies
4.4.3: Market by Application: Research, In Vitro Diagnostics, Drug Discovery and Development
4.4.4: Market by End User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers 
4.4.5: The Chinese Neuroscience Antibody and Assay Market
4.4.6: The Indian Neuroscience Antibody and Assay Market
4.4.7: The Japanese Neuroscience Antibody and Assay Market
4.5: ROW Neuroscience Antibody and Assay Market
4.5.1: Market by Product: Consumables and Reagents and Instruments
4.5.2: Market by Technology: Immunochemistry/Immunoassays, Molecular Diagnostics, Clinical Chemistry, and Other Technologies
4.5.3: Market by Application: Research, In Vitro Diagnostics, Drug Discovery and Development
4.5.4: Market by End User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers 
4.5.5: Brazilian Neuroscience Antibody and Assay Market

5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis

6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin

7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Neuroscience Antibody and Assay Market by Product
7.1.2: Growth Opportunities for the Global Neuroscience Antibody and Assay Market by Technology
7.1.3: Growth Opportunities for the Global Neuroscience Antibody and Assay Market by Application
7.1.4: Growth Opportunities for the Global Neuroscience Antibody and Assay Market by End User
7.1.5: Growth Opportunities for the Global Neuroscience Antibody and Assay Market by Region
7.2: Emerging Trends in the Global Neuroscience Antibody and Assay Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Neuroscience Antibody and Assay Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neuroscience Antibodies and Assays  Market
7.3.4: Certification and Licensing

8. Company Profiles of Leading Players
8.1: Thermo Fisher Scientific 
8.2: Abcam
8.3: Siemens 
8.4: Merck KGaA
8.5: Bio-Rad
8.6: Company 6
8.7: Company 7
8.8: Company 8
8.9: Company 9
8.10: Company 10
 
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Neuroscience Antibody and Assay Market: Trends, Forecast and Competitive Analysis Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - Neuroscience Antibody and Assay Market.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )
Have an Account / Returning Visitors?

Follow us on